Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00320255
Status:
COMPLETED
Last Update Posted:
2016-08-16
First Post:
2006-04-28
Brief Title:
A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced Metastatic Cancer
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Thrombosis |
| Cancer |
| Pulmonary Embolism |
Keywords:
| Name | View |
|---|---|
| anticoagulant | View |